Search Results

Severe burns may affect the pharmacokinetics of some drugs, resulting in the need for higher dosages

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 8, August 2009 , pp. 23-26(4)

Publisher: Adis International

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update

Authors: Shahid, M.; Sobia, F.; Singh, A.; Malik, A.; Khan, H. M.; Jonas, D.; Hawkey, P. M.

Source: Critical Reviews in Microbiology, Volume 35, Number 2, May 2009 , pp. 81-108(28)

Publisher: Informa Healthcare

Influence of Burns on Pharmacokinetics and Pharmacodynamics of Drugs Used in the Care of Burn Patients

Authors: Blanchet, Benoit; Jullien, Vincent; Vinsonneau, Christophe; Tod, Michel

Source: Clinical Pharmacokinetics, Volume 47, Number 10, 2008 , pp. 635-654(20)

Publisher: Adis International

Novel Beta-Lactam Antibiotics Derivatives: Their New Applications as Gene Reporters, Antitumor Prodrugs and Enzyme Inhibitors

Authors: Xing, Bengang; Rao, Jianghong; Liu, Rongrong

Source: Mini Reviews in Medicinal Chemistry, Volume 8, Number 5, May 2008 , pp. 455-471(17)

Publisher: Bentham Science Publishers

There is considerable regional variation in the prescribing of antibacterials for community-acquired pneumonia (CAP) across Germany

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 532, 2007-07-14 , pp. 5-5(1)

Publisher: Adis International

There is considerable regional variation in the prescribing of antibacterials for community acquired pneumonia (CAP) across Germany

Source: Inpharma, Volume 1, Number 1597, 2007-07-21 , pp. 4-4(1)

Publisher: Adis International

ID: 296

Authors: Hobson, J.; Liu, S.; Rønø, B.; Zheng, W.; Zhu, P.; Austin, C.; Inglese, J.; Leppla, S.; Bugge, T.

Source: Journal of Thrombosis and Haemostasis, Volume 4, Supplement 1, October 2006 , pp. 95-95(1)

Publisher: Blackwell Publishing

Fluoroquinolone use a risk factor for CDAD

Source: Reactions, Volume 1, Number 1084, 2006-01-14 , pp. 4-4(1)

Publisher: Adis International

New Formulations of Amoxicillin/Clavulanic Acid: A Pharmacokinetic and Pharmacodynamic Review

Author: Navarro, Amparo Sánchez

Source: Clinical Pharmacokinetics, Volume 44, Number 11, 2005 , pp. 1097-1115(19)

Publisher: Adis International

The emergence and implications of metallo--lactamases in Gram-negative bacteria

Author: Walsh, T. R.

Source: Clinical Microbiology & Infection, Volume 11, Supplement 6, November 2005 , pp. 2-9(8)

Publisher: Blackwell Publishing

A specific peptide inhibitor of the class B metallo--lactamase L-1 from Stenotrophomonas maltophilia identified using phage display

Authors: Sanschagrin, François; Levesque, Roger C.

Source: Journal of Antimicrobial Chemotherapy, Volume 55, Number 2, February 2005 , pp. 252-255(4)

Publisher: Oxford University Press

Prescribing habits of general practitioners in the treatment of childhood respiratory-tract infections

Authors: Akici, Ahmet; Kalaça, Sibel; Uğurlu, M.; Oktay, Şule

Source: European Journal of Clinical Pharmacology, Volume 60, Number 3, May 2004 , pp. 211-216(6)

Publisher: Springer

Post-antibiotic and post--lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum -lactamase-producing Gram-negative bacteria

Authors: Jean-Philippe Lavigne; Richard Bonnet; Sylvie Michaux-Charachon; Jacques Jourdan; Jocelyne Caillon; Albert Sotto

Source: Journal of Antimicrobial Chemotherapy, Volume 53, Number 4, April 2004 , pp. 616-619(4)

Publisher: Oxford University Press

-Lactamase inhibitors: evolving compounds for evolving resistance targets

Author: Nafsika H Georgopapadakou

Source: Expert Opinion on Investigational Drugs, Volume 13, Number 10, 1 October 2004 , pp. 1307-1318(12)

Publisher: Informa Healthcare

Detection and assay of -lactamases in clinical and non-clinical strains of Yersinia enterocolitica biovar 1A

Authors: Sachin Sharma; Priya Ramnani; J. S. Virdi

Source: Journal of Antimicrobial Chemotherapy, Volume 54, Number 2, 12 August 2004 , pp. 401-405(5)

Publisher: Oxford University Press

In vitro activity of AVE1330A, an innovative broad-spectrum non--lactam -lactamase inhibitor

Authors: Alain Bonnefoy; Claudine Dupuis-Hamelin; Valérie Steier; Carole Delachaume; Catherine Seys; Thérèse Stachyra; Monique Fairley; Michèle Guitton; Maxime Lampilas

Source: Journal of Antimicrobial Chemotherapy, Volume 54, Number 2, 12 August 2004 , pp. 410-417(8)

Publisher: Oxford University Press

Aluminium as an Electron Pool for Organic Synthesis - Multi-Metal Redox Promoted Reactions

Authors: Hideo Tanaka; Manabu Kuroboshi

Source: Current Organic Chemistry, Volume 8, Number 11, July 2004 , pp. 1027-1056(30)

Publisher: Bentham Science Publishers

Preface [Hot Topic: -Lactams: Synthesis, Stereochemistry, Synthons and Biological Evaluation (Guest Editor: Bimal K. Banik)]

Author: Banik B.K.

Source: Current Medicinal Chemistry, Volume 11, Number 14, July 2004 , pp. i-i(1)

Publisher: Bentham Science Publishers

-Lactams as Versatile Synthetic Intermediates for the Preparation of Heterocycles of Biological Interest

Authors: Alcaide B.; Almendros P.

Source: Current Medicinal Chemistry, Volume 11, Number 14, July 2004 , pp. 1921-1949(29)

Publisher: Bentham Science Publishers

The Discovery and Development of Modified Penicillin- and Cephalosporin- Derived -Lactamase Inhibitors

Author: Buynak J.D.

Source: Current Medicinal Chemistry, Volume 11, Number 14, July 2004 , pp. 1951-1964(14)

Publisher: Bentham Science Publishers